Emerging technologies like AI, advanced imaging, and virtual models are transforming bioequivalence testing, cutting approval times and costs for generic drugs while improving accuracy and safety.
14
Nov
Emerging technologies like AI, advanced imaging, and virtual models are transforming bioequivalence testing, cutting approval times and costs for generic drugs while improving accuracy and safety.
